Product Information
TRULANCE 3 MG TABLET is a brand product labeled by Salix Pharmaceuticals Inc., priced at $18.7793 per EA under NDC 65649000330. Its NADAC has been published 257 times since Nov 4, 2020.
FDA first approved this application on Jan 19, 2017.
Strength
3 mg/1
Manufacturer
Salix Pharmaceuticals Inc.NDC
65649000330
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Effective Date
9/17/2025
Active Ingredients
PLECANATIDEApproval Type
New Drug (NDA)
FDA Application
NDA208745FDA Approved
1/19/2017
On Market Since
2/21/2017
Pharmacological Classes
Price Statistics
The NADAC for TRULANCE 3 MG TABLET has been published 257 times since Nov 4, 2020, and over the history we have for it it has risen 34.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $18.7793 per EA |
|---|---|
| All-time high | $18.7793 (Oct 1, 2025) |
| All-time low | $13.9676 (Nov 4, 2020) |
| Median price | $17.2475 |
| Average price | $16.7246 |
| Largest weekly change | +7.9% (Jan 12, 2022) |
| Weeks tracked | 257 |
| Tracking since | Nov 4, 2020 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
+8.9%
5Y
+24.5%
All
+34.4%
Last surveyed Oct 1, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Plecanatide market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Salix Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Plecanatide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TRULANCE 3 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TRULANCE 3 MG TABLET, manufactured by Salix Pharmaceuticals Inc., is $18.7793 per EA (NDC 65649000330), effective Oct 1, 2025.
How has the price of TRULANCE 3 MG TABLET changed over time?
Over the history we have for it, the NADAC for TRULANCE 3 MG TABLET has risen 34.4%. It has been tracked across 257 weekly CMS publications since Nov 4, 2020.
What are the highest and lowest recorded NADAC prices for TRULANCE 3 MG TABLET?
Since Nov 4, 2020, the NADAC for TRULANCE 3 MG TABLET has ranged from a low of $13.9676 (Nov 4, 2020) to a high of $18.7793 (Oct 1, 2025), with a median of $17.2475 per EA.
Are there cheaper alternatives to TRULANCE 3 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of TRULANCE 3 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures TRULANCE 3 MG TABLET?
TRULANCE 3 MG TABLET (NDC 65649000330) is labeled by Salix Pharmaceuticals Inc., and CMS classifies it as a brand product.